581 related articles for article (PubMed ID: 35445415)
1. SARS-CoV-2 Delta-variant breakthrough infections in nursing home residents at midterm after Comirnaty® COVID-19 vaccination.
Torres I; Bellido-Blasco JB; Gimeno C; Burgos JS; Albert E; Moya-Malo R; Gascó-Laborda JC; Tornero A; Soriano J; Meseguer-Ferrer N; Martínez-Serrano M; Ortíz-Rambla J; Buj H; Hernández N; Peiró S; Salas D; Limón R; Vanaclocha H; Sánchez-Payá J; Díez-Domingo J; Comas I; González-Candelas F; Navarro D;
J Med Virol; 2022 Aug; 94(8):3776-3782. PubMed ID: 35445415
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 Omicron BA.1 variant breakthrough infections in nursing home residents after an homologous third dose of the Comirnaty® COVID-19 vaccine: Looking for correlates of protection.
Torres I; Giménez E; Albert E; Zulaica J; Álvarez-Rodríguez B; Burgos JS; Peiró S; Limón R; Vanaclocha H; Rodado C; Botija P; Sifre A; Tur B; Lozano RA; Orosa I; Vicente-Ruiz M; Carrión RJ; Clari MÁ; Sánchez-Payá J; Díez-Domingo J; Comas I; González-Candelas F; Geller R; Navarro D;
J Med Virol; 2022 Sep; 94(9):4216-4223. PubMed ID: 35585782
[TBL] [Abstract][Full Text] [Related]
3. Immunological response against SARS-CoV-2 following full-dose administration of Comirnaty® COVID-19 vaccine in nursing home residents.
Albert E; Burgos JS; Peiró S; Salas D; Vanaclocha H; Giménez E; Limón R; Alcaraz MJ; Sánchez-Payá J; Díez-Domingo J; Navarro D;
Clin Microbiol Infect; 2022 Feb; 28(2):279-284. PubMed ID: 34619398
[TBL] [Abstract][Full Text] [Related]
4. B- and T-cell immune responses elicited by the Comirnaty® COVID-19 vaccine in nursing-home residents.
Torres I; Albert E; Giménez E; Alcaraz MJ; Botija P; Amat P; Remigia MJ; Beltrán MJ; Rodado C; Huntley D; Olea B; Navarro D
Clin Microbiol Infect; 2021 Nov; 27(11):1672-1677. PubMed ID: 34174397
[TBL] [Abstract][Full Text] [Related]
5. Persistence and Protective Potential of SARS-CoV-2 Antibody Levels After COVID-19 Vaccination in a West Virginia Nursing Home Cohort.
Smoot K; Yang J; Tacker DH; Welch S; Khodaverdi M; Kimble W; Wen S; Amjad A; Marsh C; Perrotta PL; Hodder S
JAMA Netw Open; 2022 Sep; 5(9):e2231334. PubMed ID: 36098966
[TBL] [Abstract][Full Text] [Related]
6. Previous SARS-CoV-2 Infection, Age, and Frailty Are Associated With 6-Month Vaccine-Induced Anti-Spike Antibody Titer in Nursing Home Residents.
Dyer AH; Noonan C; McElheron M; Batten I; Reddy C; Connolly E; Pierpoint R; Murray C; Leonard A; Higgins C; Reilly P; Boran G; Phelan T; McCormack W; O'Neill D; Fallon A; Brady G; O'Farrelly C; Bourke NM; Kennelly SP
J Am Med Dir Assoc; 2022 Mar; 23(3):434-439. PubMed ID: 35219507
[TBL] [Abstract][Full Text] [Related]
7. Outbreak of SARS-CoV-2 B.1.617.2 (delta) variant in a nursing home 28 weeks after two doses of mRNA anti-COVID-19 vaccines: evidence of a waning immunity.
Pierobon A; Zotto AD; Antico A; De Antoni ME; Vianello L; Gennari M; Di Caprio A; Russo F; Brambilla G; Saugo M
Clin Microbiol Infect; 2022 Apr; 28(4):614.e5-614.e7. PubMed ID: 34958917
[TBL] [Abstract][Full Text] [Related]
8. Pronounced antibody elevation after SARS-CoV-2 BNT162b2 mRNA booster vaccination in nursing home residents.
Chong Y; Goto T; Tani N; Yonekawa A; Ikematsu H; Shimono N; Tanaka Y; Akashi K
Influenza Other Respir Viruses; 2022 Nov; 16(6):1066-1071. PubMed ID: 35962568
[TBL] [Abstract][Full Text] [Related]
9. Poor Antibody Response to BioNTech/Pfizer Coronavirus Disease 2019 Vaccination in Severe Acute Respiratory Syndrome Coronavirus 2-Naive Residents of Nursing Homes.
Pannus P; Neven KY; De Craeye S; Heyndrickx L; Vande Kerckhove S; Georges D; Michiels J; Francotte A; Van Den Bulcke M; Zrein M; Van Gucht S; Schmickler MN; Verbrugghe M; Matagne A; Thomas I; Dierick K; Weiner JA; Ackerman ME; Goriely S; Goossens ME; Ariën KK; Desombere I; Marchant A
Clin Infect Dis; 2022 Aug; 75(1):e695-e704. PubMed ID: 34864935
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021.
Nanduri S; Pilishvili T; Derado G; Soe MM; Dollard P; Wu H; Li Q; Bagchi S; Dubendris H; Link-Gelles R; Jernigan JA; Budnitz D; Bell J; Benin A; Shang N; Edwards JR; Verani JR; Schrag SJ
MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(34):1163-1166. PubMed ID: 34437519
[TBL] [Abstract][Full Text] [Related]
11. Humoral anti-SARS-CoV-2 immune response after two doses of Comirnaty vaccine in nursing home residents by previous infection status.
Helle F; Moyet J; Demey B; François C; Duverlie G; Castelain S; Bloch F; Brochot E
Vaccine; 2022 Jan; 40(3):531-535. PubMed ID: 34893341
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of Coronavirus Disease 2019 (COVID-19) Vaccination Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Among Residents of US Nursing Homes Before and During the Delta Variant Predominance, December 2020-November 2021.
Hatfield KM; Baggs J; Wolford H; Fang M; Sattar AA; Montgomery KS; Jin S; Jernigan J; Pilishvili T
Clin Infect Dis; 2022 Oct; 75(Suppl 2):S147-S154. PubMed ID: 35856635
[TBL] [Abstract][Full Text] [Related]
13. Long-term effects of SARS-CoV-2 vaccination in the nursing home setting.
Rivasi G; Bulgaresi M; Bandinelli C; Balzi D; Tarantini F; Tognelli S; Lorini C; Buscemi P; Baggiani L; Landini G; Ungar A; Bonaccorsi G; Mossello E; Benvenuti E
J Am Geriatr Soc; 2022 May; 70(5):1336-1341. PubMed ID: 35347706
[TBL] [Abstract][Full Text] [Related]
14. Evaluating immunity to SARS-CoV-2 in nursing home residents using saliva IgG.
Katz MJ; Heaney CD; Pisanic N; Smith L; Bigelow BF; Sheikh F; Boudreau A; Kruczynski K; Hsu YJ; Salinas AB; Cosgrove SE; Rock C
J Am Geriatr Soc; 2022 Mar; 70(3):659-668. PubMed ID: 35038344
[TBL] [Abstract][Full Text] [Related]
15. Neutralizing antibodies against SARS-CoV-2 variants of concern elicited by the comirnaty COVID-19 vaccine in nursing home residents.
Sánchez-Sendra B; Albert E; Zulaica J; Torres I; Giménez E; Botija P; Beltrán MJ; Rodado C; Geller R; Navarro D
Sci Rep; 2022 Mar; 12(1):3788. PubMed ID: 35260713
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal serologic and viral testing post-SARS-CoV-2 infection and post-receipt of mRNA COVID-19 vaccine in a nursing home cohort-Georgia, October 2020‒April 2021.
Tobolowsky FA; Waltenburg MA; Moritz ED; Haile M; DaSilva JC; Schuh AJ; Thornburg NJ; Westbrook A; McKay SL; LaVoie SP; Folster JM; Harcourt JL; Tamin A; Stumpf MM; Mills L; Freeman B; Lester S; Beshearse E; Lecy KD; Brown LG; Fajardo G; Negley J; McDonald LC; Kutty PK; Brown AC;
PLoS One; 2022; 17(10):e0275718. PubMed ID: 36301805
[TBL] [Abstract][Full Text] [Related]
17. Severe Acute Respiratory Syndrome Coronavirus 2 Adaptive Immunity in Nursing Home Residents Following a Third Dose of the Comirnaty Coronavirus Disease 2019 Vaccine.
Giménez E; Albert E; Zulaica J; Torres I; Rusu L; Moreno AR; Burgos JS; Peiró S; Salas D; Vanaclocha H; Limón R; Alcaraz MJ; Sánchez-Payá J; Díez-Domingo J; Comas I; Gonzáles-Candelas F; Geller R; Navarro D;
Clin Infect Dis; 2022 Aug; 75(1):e865-e868. PubMed ID: 35314856
[TBL] [Abstract][Full Text] [Related]
18. Post-vaccination antibody evaluation for nosocomial SARS-CoV-2 delta variant breakthrough infection.
Goto T; Tani N; Ikematsu H; Gondo K; Oishi R; Minami J; Onozawa K; Kuwano H; Akashi K; Shimono N; Chong Y
PLoS One; 2022; 17(7):e0272056. PubMed ID: 35877668
[TBL] [Abstract][Full Text] [Related]
19. Achievement of sufficient antibody response after a fourth dose of wild-type SARS-CoV-2 mRNA vaccine in nursing home residents.
Chong Y; Goto T; Watanabe H; Tani N; Yonekawa A; Ikematsu H; Shimono N; Tanaka Y; Akashi K
Immun Inflamm Dis; 2023 Aug; 11(8):e962. PubMed ID: 37647452
[TBL] [Abstract][Full Text] [Related]
20. Antibody and cellular immune responses following dual COVID-19 vaccination within infection-naive residents of long-term care facilities: an observational cohort study.
Tut G; Lancaster T; Sylla P; Butler MS; Kaur N; Spalkova E; Bentley C; Amin U; Jadir A; Hulme S; Ayodele M; Bone D; Tut E; Bruton R; Krutikov M; Giddings R; Shrotri M; Azmi B; Fuller C; Baynton V; Irwin-Singer A; Hayward A; Copas A; Shallcross L; Moss P
Lancet Healthy Longev; 2022 Jul; 3(7):e461-e469. PubMed ID: 35813280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]